No Data
Express News | New Post-Hoc Analysis Of Pooled Phase 3 Data Shows That INPEFA (Sotagliflozin) Reduced Risk Of Heart Failure Events In Patients With Preserved Ejection Fraction
12 Health Care Stocks Moving In Tuesday's Intraday Session
GainersNuwellis (NASDAQ:NUWE) shares rose 57.7% to $0.27 during Tuesday's regular session. The company's market cap stands at $4.1 million. As per the news, the Q1 earnings report came out today. Biov
Jefferies Cuts Lyra to Hold in Wake of Failed Phase 3 Study
Where Lyra Therapeutics Stands With Analysts
Analysts' ratings for Lyra Therapeutics (NASDAQ:LYRA) over the last quarter vary from bullish to bearish, as provided by 5 analysts.The table below provides a snapshot of their recent ratings, showcas
Lyra Therapeutics Price Target Announced at $2.00/Share by HC Wainwright & Co.
Lyra Therapeutics Price Target Announced at $2.00/Share by HC Wainwright & Co.
Express News | Lyra Therapeutics Shares Are Trading Lower on Continued Weakness After the Company on Monday Announced the ENLIGHTEN 1 Trial Did Not Meet Its Primary Endpoint. Also, Jefferies Downgraded the Stock From Buy to Hold and Lowered Its Price Target From $10...